Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women

被引:27
作者
Anastos, Kathryn [1 ,2 ]
Hoover, Donald R. [3 ,4 ]
Burk, Robert D. [5 ]
Cajigas, Antonio [6 ]
Shi, Qiuhu [7 ]
Singh, Diljeet K. [8 ]
Cohen, Mardge H. [9 ,10 ]
Mutimura, Eugene [11 ]
Sturgis, Charles [12 ]
Banzhaf, William C. [13 ]
Castle, Philip E. [14 ]
机构
[1] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[3] Rutgers State Univ, Dept Stat, Piscataway, NJ USA
[4] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA
[5] Albert Einstein Coll Med, Dept Pediat, Div Genet, Bronx, NY 10467 USA
[6] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA
[7] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA
[8] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[9] John Stroger Hosp, Chicago, IL USA
[10] Rush Univ, Chicago, IL 60612 USA
[11] Womens Equ Access Care & Treatment, Kigali, Rwanda
[12] Providence Reg Med Ctr, Everett, WA USA
[13] Univ Chicago, Pritzker Sch Med, Evanston, IL USA
[14] NCI, NIH, US Dept HHS, Bethesda, MD 20892 USA
来源
PLOS ONE | 2010年 / 5卷 / 10期
基金
美国国家卫生研究院;
关键词
HUMAN-PAPILLOMAVIRUS INFECTION; NATURAL-HISTORY; NEOPLASIA; POPULATION; DIAGNOSIS; DNA; BIOPSY;
D O I
10.1371/journal.pone.0013525
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Although cervical cancer is an AIDS-defining condition, infection with human immunodeficiency virus (HIV) may only modestly increase the risk of cervical cancer. There is a paucity of information regarding factors that influence the natural history of human papillomavirus (HPV) in HIV-infected women. We examined factors associated with cervical intraepithelial neoplasia grade 3 or cancer (CIN3+) in Rwandan women infected with both HIV and HPV (HIV+/HPV+). Methods: In 2005, 710 HIV+ Rwandan women >= 25 years enrolled in an observational cohort study; 476 (67%) tested HPV+. Each woman provided sociodemographic data, CD4 count, a cervical cytology specimen and cervicovaginal lavage (CVL), which was tested for >40 HPV genotypes by MY09/MY11 PCR assay. Logistic regression models calculated odds ratios (OR) and 95% confidence intervals (CI) of associations of potential risk factors for CIN3+ among HIV+/HPV+ women. Results: Of the 476 HIV+/HPV+ women 42 (8.8%) were diagnosed with CIN3+. Factors associated with CIN3+ included >= 7 (vs. 0-2) pregnancies, malarial infection in the previous six months (vs. never), and >= 7 (vs. 0-2) lifetime sexual partners. Compared to women infected by non-HPV16 carcinogenic HPV genotypes, HPV16 infection was positively associated and non-carcinogenic HPV infection was inversely associated with CIN3+. CD4 count was significantly associated with CIN3+ only in analyses of women with non-HPV16 carcinogenic HPV (OR = 0.62 per 100 cells/mm(3), CI = 0.40-0.97). Conclusions: In this HIV+/HPV+ population, lower CD4 was significantly associated with CIN3+ only in women infected with carcinogenic non-HPV16. We found a trend for higher risk of CIN3+ in HIV+ women reporting recent malarial infection; this association should be investigated in a larger group of HIV+/HPV+ women.
引用
收藏
页数:6
相关论文
共 27 条
  • [1] A review of human carcinogens-Part B: biological agents
    Bouvard, Veronique
    Baan, Robert
    Straif, Kurt
    Grosse, Yann
    Secretan, Beatrice
    El Ghissassi, Fatiha
    Benbrahim-Tallaa, Lamia
    Guha, Neela
    Freeman, Crystal
    Galichet, Laurent
    Cogliano, Vincent
    [J]. LANCET ONCOLOGY, 2009, 10 (04) : 321 - 322
  • [2] CIN2 is a much less reproducible and less valid diagnosis than CIN3: Results from a histological review of population-based cervical samples
    Carreon, Joseph D.
    Sherman, Mark E.
    Guillen, Diego
    Solomon, Diane
    Herrero, Rolando
    Jeronimo, Jose
    Wacholder, Sholom
    Rodriguez, Ana Cecilia
    Morales, Jorge
    Hutchinson, Martha
    Burk, Robert D.
    Schiffman, Mark
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2007, 26 (04) : 441 - 446
  • [3] Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20
  • [4] Age-related changes of the cervix influence human papillomavirus type distribution
    Castle, PE
    Jeronimo, J
    Schiffman, M
    Herrero, R
    Rodríguez, AC
    Bratti, MC
    Hildesheim, A
    Wacholder, S
    Long, LR
    Neve, L
    Pfeiffer, R
    Burk, RD
    [J]. CANCER RESEARCH, 2006, 66 (02) : 1218 - 1224
  • [5] A population-based study of vaginal human papillomavirus infection in hysterectomized women
    Castle, PE
    Schiffman, M
    Bratti, MC
    Hildesheim, A
    Herrero, R
    Hutchinson, ML
    Rodriguez, AC
    Wacholder, S
    Sherman, ME
    Kendall, H
    Viscidi, RP
    Jeronimo, J
    Schussler, JE
    Burk, RD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (03) : 458 - 467
  • [6] Comparisons of HPV DNA detection by MY09/11 PCR methods
    Castle, PE
    Schiffman, M
    Gravitt, PE
    Kendall, H
    Fishman, S
    Dong, H
    Hildesheim, A
    Herrero, R
    Bratti, MC
    Sherman, ME
    Lorincz, A
    Schussler, JE
    Burk, RD
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (03) : 417 - 423
  • [7] An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL triage study (ALTS)
    Castle, Philip E.
    Cox, J. Thomas
    Jeronimo, Jose
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 111 (04) : 847 - 856
  • [8] The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses - An ALTS report
    Castle, Philip E.
    Stoler, Mark H.
    Solomon, Diane
    Schiffman, Mark
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (05) : 805 - 815
  • [9] Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2
    Castle, Philip E.
    Schiffinan, Mark
    Eeler, Cosette M.
    Solomon, Diane
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 113 (01) : 18 - 25
  • [10] Cancer risk in HIV-infected persons: influence of CD4+ count
    Clifford, Gary M.
    Franceschi, Silvia
    [J]. FUTURE ONCOLOGY, 2009, 5 (05) : 669 - 678